Skip to main content

The U.S. Food and Drug Administration has issued an emergency use authorization for a new flu drug, the first new flu antiviral in years.

The drug is called Peramivir and it is made by the American company BioCryst Pharmaceuticals.

The drug is in the same class of drugs as the two key flu drugs, Tamiflu and Relenza, but is given intravenously.

Story continues below advertisement

Hospital based specialists who treat severely ill flu patients have been pressing for development of an IV flu drug for use in patients who can't take oral flu drugs or Relenza, which is inhaled.

The FDA says it approved the drug on the request of the Centers for Disease Control.

Infectious disease expert Allison McGeer of Toronto's Mount Sinai Hospital says she thinks Canadian doctors may be able to access the drug for severely ill H1N1 patients through Health Canada's emergency release system, if the company has adequate supplies of the drug.

Report an error
Comments

The Globe invites you to share your views. Please stay on topic and be respectful to everyone. For more information on our commenting policies and how our community-based moderation works, please read our Community Guidelines and our Terms and Conditions.

We’ve made some technical updates to our commenting software. If you are experiencing any issues posting comments, simply log out and log back in.

Discussion loading… ✨

Combined Shape Created with Sketch.

Combined Shape Created with Sketch.

Thank you!

You are now subscribed to the newsletter at

You can unsubscribe from this newsletter or Globe promotions at any time by clicking the link at the bottom of the newsletter, or by emailing us at privacy@globeandmail.com.